Rituximab

Rituximab is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis.

Rituximab is a monoclonal antibody. It works by targeting the unwanted activity of immune cells (B cells) in rheumatoid arthritis and certain types of cancers.

Headache, Weakness, Infection, Chills, Decreased white blood cell count (neutrophils), Fever, Infusion site reaction, Lymphopenia, Abdominal pain, Back pain